Article 1 to 1 out of 1 concerning Laboratoires Pierre Fabre SA
LibraGen signs partnership agreement with Pierre Fabre Medicament R&D(01/09/2006) LibraGen will use its industrial biocatalysis know-how to carry out research into optimizing the synthesis of a pharmaceutical molecule LibraGen announced that it has signed a partnership agreement with the R&D department of Pierre Fabre Medicament, France's second largest independent pharmaceutical company. Under the terms of the agreement, LibraGen will use enzymatic technologies ...